{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:17:03Z","timestamp":1788412623374,"version":"build-2803163510"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-15-00066"],"award-info":[{"award-number":["24-15-00066"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["24-15-00066"],"award-info":[{"award-number":["24-15-00066"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Herpes simplex encephalitis (HSE) remains a life-threatening disease with high mortality and severe neurological complications, despite acyclovir therapy being limited by delayed diagnosis, drug resistance, and poor blood\u2013brain barrier penetration. New antivirals with different mechanisms of action are urgently needed. We evaluated PDSTP, a novel dispirotripiperazine-based compound targeting host heparan sulfate proteoglycans (HSPGs), in mouse models of HSV-1 encephalitis. This study evaluates the therapeutic and prophylactic potential of PDSTP, an antiviral compound that blocks HSV glycoconjugates on the host cell membrane, using a well-established mouse model of herpes encephalitis. BALB\/c mice were infected with HSV-1 strains VR-539 or VR-733 via intraperitoneal (IP) or intranasal (IN) routes. PDSTP was administered orally (PO) or intraperitoneally (IP) at 12.5\u201380 mg\/kg\/day, alone or in combination with acyclovir (10\u2013100 mg\/kg\/day), using a prophylactic\u2013therapeutic regimen (2 h pre-infection, then twice daily for 7 days). Survival, weight loss, mean survival time, and brain viral loads were assessed. PDSTP at 80 mg\/kg\/day (PO) protected 30\u201340% of VR-733-infected mice and extended lifespan 1.9-fold (p &lt; 0.05), comparable to acyclovir at 100 mg\/kg\/day. IP administration was superior to PO. The combination of IP PDSTP (12.5 mg\/kg\/day) with IP acyclovir (10 mg\/kg\/day) achieved 100% survival, prevented weight loss, and significantly reduced brain viral titers (p &lt; 0.001) in both infection models. PDSTP demonstrates dose- and strain-dependent activity as monotherapy and enhanced efficacy when combined with acyclovir. The IP combination provided complete protection at low doses, supporting PDSTP as a promising candidate for further development against HSE.<\/jats:p>","DOI":"10.3390\/v18090944","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:41:18Z","timestamp":1788266478000},"page":"944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Proof-of-Concept Study for the Efficacy of Dispirotripiperazine PDSTP in a Mouse Model of Herpes Simplex Herpetic Encephalitis"],"prefix":"10.3390","volume":"18","author":[{"given":"Kristina","family":"Pomeshikova","sequence":"first","affiliation":[{"name":"Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, Moscow 119071, Russia"},{"name":"I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Riabova","sequence":"additional","affiliation":[{"name":"Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, Moscow 119071, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Monakhova","sequence":"additional","affiliation":[{"name":"Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, Moscow 119071, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Leneva","sequence":"additional","affiliation":[{"name":"Department of Virology, Mechnikov Research Institute of Vaccines and Sera, Moscow 105064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-4263","authenticated-orcid":false,"given":"Giuseppina","family":"Sanna","sequence":"additional","affiliation":[{"name":"Microbiology and Virology Unit, Department of Biomedical Science, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-2694","authenticated-orcid":false,"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[{"name":"Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), 33-2 Leninsky Prospect, Moscow 119071, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106152","DOI":"10.1016\/j.antiviral.2025.106152","article-title":"Overview on the management of herpes simplex virus infections: Current therapies and future directions","volume":"237","author":"Birkmann","year":"2025","journal-title":"Antivir. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/brain\/awad419","article-title":"The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity","volume":"147","author":"Cleaver","year":"2024","journal-title":"Brain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","article-title":"Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management","volume":"13","author":"Bradshaw","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00105-19","article-title":"Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis","volume":"33","author":"Piret","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Egan, K.P., Awasthi, S., Tebaldi, G., Hook, L.M., Naughton, A.M., Fowler, B.T., Beattie, M., Alameh, M.-G., Weissman, D., and Cohen, G.H. (2023). A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1. Viruses, 15.","DOI":"10.3390\/v15071483"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.00335-20","article-title":"A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, \u0394gD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus","volume":"94","author":"Ramsey","year":"2020","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hayashi, K., Lee, J.B., Atsumi, K., Kanazashi, M., Shibayama, T., Okamoto, K., Kawahara, T., and Hayashi, T. (2019). In vitro and in vivo anti-herpes simplex virus activity of monogalactosyl diacylglyceride from Coccomyxa sp. KJ (IPOD FERM BP-22254), a green microalga. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219305"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Agelidis, A., Koujah, L., Suryawanshi, R., Yadavalli, T., Mishra, Y.K., Adelung, R., and Shukla, D. (2019). An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00500"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/v7010352","article-title":"Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state","volume":"7","author":"Cho","year":"2015","journal-title":"Viruses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/AAC.01964-13","article-title":"DSTP-27 prevents entry of human cytomegalovirus","volume":"58","author":"Paeschke","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02103-20","article-title":"Diazadispiroalkane Derivatives Are New Viral Entry Inhibitors","volume":"65","author":"Adfeldt","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105402","DOI":"10.1016\/j.antiviral.2022.105402","article-title":"Broad-spectrum antiviral diazadispiroalkane core molecules block attachment and cell-to-cell spread of herpesviruses","volume":"206","author":"Dohme","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113014","DOI":"10.1016\/j.ejmech.2020.113014","article-title":"Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review)","volume":"211","author":"Egorova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bonacorsi, A., Trespidi, G., Scoffone, V.C., Irudal, S., Barbieri, G., Riabova, O., Monakhova, N., Makarov, V., and Buroni, S. (2024). Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1357708"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105327","DOI":"10.1016\/j.antiviral.2022.105327","article-title":"A proof-of-concept study for the efficacy of dispirotripiperazine PDSTP in a rabbit model of herpes simplex epithelial keratitis","volume":"202","author":"Alimbarova","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0166-3542(02)00014-1","article-title":"Synthesis, cytotoxicity and antiviral activity of N,N\u2019-bis-5-nitropyrimidyl derivatives of dispirotripiperazine","volume":"55","author":"Schmidtke","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0042-6822(03)00166-1","article-title":"Binding of a N,N\u2019-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families","volume":"311","author":"Schmidtke","year":"2003","journal-title":"Virology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.00998-07","article-title":"Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus","volume":"81","author":"Selinka","year":"2007","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003495-199447010-00009","article-title":"Acyclovir: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy","volume":"47","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamainternmed.2019.5713","article-title":"Acyclovir for Mechanically Ventilated Patients with Herpes Simplex Virus Oropharyngeal Reactivation: A Randomized Clinical Trial","volume":"180","author":"Luyt","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00003495-198326050-00002","article-title":"Acyclovir: A review of its pharmacodynamic properties and therapeutic efficacy","volume":"26","author":"Richards","year":"1983","journal-title":"Drugs"},{"key":"ref_22","first-page":"96","article-title":"Effectiveness of topical acyclovir preventive-therapeutic of herpes simlex labialis in children","volume":"13","author":"Kazantseva","year":"2016","journal-title":"J. Volgogr. State Med. Univ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11094-019-02079-9","article-title":"Specific Antiviral Activity of Pyrimidinedispirotripiperazinium Alone and in Combination with Acyclovir on a Herpes-Simplex-Virus Infection Model","volume":"53","author":"Novoselova","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/iai.40.1.103-112.1983","article-title":"Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB\/c mice","volume":"40","author":"Dix","year":"1983","journal-title":"Infect. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e70178","DOI":"10.1002\/glia.70178","article-title":"Herpes Simplex Virus Type 1 Infects Schwann Cells via Exosomal CD81, Exploits the MVB-Exosomal Pathway, and Induces Demyelination","volume":"74","author":"Kang","year":"2026","journal-title":"Glia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117099","DOI":"10.1016\/j.celrep.2026.117099","article-title":"Enucleated cells with Nectin-1 overexpression capture HSV-1 and promote viral elimination for herpes simplex encephalitis therapy","volume":"45","author":"Zhou","year":"2026","journal-title":"Cell Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108589","DOI":"10.1016\/j.bioorg.2025.108589","article-title":"Design, synthesis, and in-vitro\/in-vivo pharmacodynamic studies of novel aza-fused heterocyclic compounds against herpes simplex virus type 1","volume":"162","author":"Xue","year":"2025","journal-title":"Bioorg. Chem."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:44:44Z","timestamp":1788410684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["v18090944"],"URL":"https:\/\/doi.org\/10.3390\/v18090944","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}